These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Mellinghoff SC; Panse J; Alakel N; Behre G; Buchheidt D; Christopeit M; Hasenkamp J; Kiehl M; Koldehoff M; Krause SW; Lehners N; von Lilienfeld-Toal M; Löhnert AY; Maschmeyer G; Teschner D; Ullmann AJ; Penack O; Ruhnke M; Mayer K; Ostermann H; Wolf HH; Cornely OA Ann Hematol; 2018 Feb; 97(2):197-207. PubMed ID: 29218389 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967 [TBL] [Abstract][Full Text] [Related]
6. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients. Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404 [TBL] [Abstract][Full Text] [Related]
8. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease. Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology and Factors Associated with Treatment Success of Invasive Fungal Infections Among Newly Hematologic Malignancy Patients Receiving Chemotherapy or Hematopoietic Stem Cell Transplant in Thailand. Weeraphon B; Nakaranurack C; Jutivorakool K; Puttilerpong C Infect Drug Resist; 2023; 16():2029-2042. PubMed ID: 37041985 [TBL] [Abstract][Full Text] [Related]
10. [Current approaches to diagnosis and treatment of invasive fungal infection in HSCT recipients]. Shao Q; Shen DX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1619-23. PubMed ID: 20030960 [TBL] [Abstract][Full Text] [Related]
11. Changing Epidemiology of Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplantation. Puerta-Alcalde P; Garcia-Vidal C J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682269 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients. Peghin M; Monforte V; Martin-Gomez MT; Ruiz-Camps I; Berastegui C; Saez B; Riera J; Solé J; Gavaldá J; Roman A Transpl Infect Dis; 2016 Feb; 18(1):70-8. PubMed ID: 26678668 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology and treatment approaches in management of invasive fungal infections. Kriengkauykiat J; Ito JI; Dadwal SS Clin Epidemiol; 2011; 3():175-91. PubMed ID: 21750627 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia. Chang A; Musk M; Lavender M; Wrobel J; Yaw MC; Lawrence S; Chirayath S; Boan P Transpl Infect Dis; 2019 Jun; 21(3):e13085. PubMed ID: 30925010 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens. Corzo-León DE; Satlin MJ; Soave R; Shore TB; Schuetz AN; Jacobs SE; Walsh TJ Mycoses; 2015 Jun; 58(6):325-36. PubMed ID: 25808822 [TBL] [Abstract][Full Text] [Related]
17. [The clinical characteristic and risk factors for the incidence of invasive fungal infection in patients following allogeneic hematopoietic stem cell transplantation]. Zhang Y; Liu C; Liu QF; Sun J; Fan ZP; Xu D; Jiang QL Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2814-7. PubMed ID: 20137659 [TBL] [Abstract][Full Text] [Related]
18. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study. Kuster S; Stampf S; Gerber B; Baettig V; Weisser M; Gerull S; Medinger M; Passweg J; Schanz U; Garzoni C; Berger C; Chalandon Y; Mueller NJ; van Delden C; Neofytos D; Khanna N; Transpl Infect Dis; 2018 Dec; 20(6):e12981. PubMed ID: 30144374 [TBL] [Abstract][Full Text] [Related]